Back to search

Article

Emerging AI and Biomarker–Driven Precision Medicine in Autoimmune Rheumatic Diseases: From Diagnostics to Therapeutic Decision-Making

2025-10-13

Abstract excerpt

Autoimmune rheumatic diseases (AIRD) are heterogeneous, relapsing–remitting disorders in which early diagnosis, flare prediction, and individualized treatment selection remain critical unmet needs. Recent advances in multimodal biomarkers—including serological and inflammatory markers, quantitative imaging (ultrasound/MRI), -omics signatures (e.g., interferon- and B-cell–related programs), and digital phenotypes f...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
5c7850ed-fbc5-5c20-b599-e32678f4d8a9
DOI
10.20944/preprints202510.0839.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Emerging AI and Biomarker–Driven Precision Medicine in Autoimmune Rheumatic Diseases: From Diagnostics to Therapeutic Decision-MakingDOI 10.20944/preprints202510.0839.v1
Select a neighboring publication to make it the new centre.